CHANSE Technology 500L Coating Machine, Made in China to help pharmaceutical production in the post epidemic era
BY:
Solid Preparation
Stainless Steel Products
Disposable Products
Disposables
Hot Melt Extrusion
Process Analysis
Continuous Granulation
Process Services
Intelligent Manufacturing
Empcv Turnkey Service
Preface
In the winter month of renyin, the decalogue is approaching. Under the leadership of the Communist Party of China, the new Ten epidemic prevention and control measures have been implemented, and the three-year fight against the epidemic has entered the next stage, guiding the general public to enhance personal protection awareness.
CHANSE Technology as a pharmaceutical equipment service provider is committed to the drug solid preparations, biological products, complex liquid preparations, disposable biological products and other areas of the overall solution. In the post-epidemic era, the high-efficiency coating machine of CHANSE Technology helps the production and preparation of oral solid drugs and the production process, contributing to the medical industry, making a lifting device for China's wisdom, and escorts the safety of the people.
CHANSE Technology CM Series Coating Machine
Product IntroductionIntroduction
Coating machine working principle:
The coating cylinder rotates while driving the core to make continuous movement, and the coating material is coated on the surface of the core by peristaltic pump and high performance spray gun. Through the air inlet air processing unit to provide clean hot air to the coating machine, the coating of drugs for drying, the rest of the hot air through the exhaust air processing unit discharged through the precise control of the entire coating process, so that the surface of the core of the drug to form a layer of dense, smooth, uniform coating film.
Process and purpose of film coating:
Film coating process is a new type of process, which first arose in the pharmaceutical industry for the protection of tablets. Compared with sugar coating, it has the characteristics of short production cycle, less material, strong moisture resistance, etc. In the coating process, according to the different solvents, it can be divided into water-soluble coating process and organic solvent coating process.
The purpose of film coating is to improve the appearance and ease of identification, mask bad odors, easy for patients to take, reduce gastrointestinal reactions, control drug release, change the drug release curve, moisture, light, air insulation to increase the stability of the drug. There will be changes in the composition of the drugs are placed in the heart of the film and the coat or separately coated after the unified pressure film to avoid other changes.
Product AdvantagesFeatures
Ø Uniform and stable airflow structure
Ø Precise and stable control of air inlet temperature and humidity
Ø Suspended pot body, eliminating cross contamination
Ø Shark-fin stirring paddle, avoiding tablet knocking and debris.
Ø Flexible replacement of multi-specification material pots
Ø Advanced customized spray gun atomization system to maintain stable liquid supply and atomization, CIP automatic gun clearing.
(Shark fin mixing paddles)
Domestic oral new crown drug latest information:
The randomized, double-blind, placebo-controlled Phase III clinical study of RAY1216 tablets, a domestic new crown potent drug under development for the treatment of patients with mild and common new crown infections, has completed the enrollment of the first subject, marking the full-scale launch of the Phase III clinical.
It is worth mentioning that RAY1216 tablets are intended to be used for the treatment of patients with neocoronavirus infection, which is the same 3CL protease inhibitor technology route as Paxlovid, the marketed neocoronavirus oral drug of Pfizer, which is also expected to be the first domestic neocoronavirus potent drug targeting 3CL protease.
In addition to the conditional approval of Azulfidine tablets, a number of new crown oral drugs are in rapid progress, Zhongsheng Pharmaceutical, Simcere Pharmaceutical, Junshi Biological, Guangshengtang and other new crown drugs have entered the phase III clinical stage, one step away from approval.
CHANSE Technology can provide some of the equipment required for the production of such products: